Literature DB >> 11402382

Quantitative analysis of intravitreal injections in the rat.

P Dureau1, S Bonnel, M Menasche, J L Dufier, M Abitbol.   

Abstract

Intravitreal injections are currently used in the rat to introduce a therapeutic factor in the eye, especially for experimental treatments of retinal degenerations. The injected volume and its location can influence the quantification of results. We have investigated the quantitative effect of a single intravitreal injection in rats at different ages and for different volumes. Albinos rats aged three weeks or two months received intravitreal injections of 1, 3, 5 or 10 microl China ink. Animals were sacrificed immediately after injection, eyes were enucleated, fixated, embedded in paraffin and microtomy was performed in a sagittal plane. Regularly spaced sections were analyzed to reconstruct the vitreous and injected dye volumes. The measured vitreous volume was 6.76 +/- 0.37 mm(3) in three weeks old rats and 13.36 +/- 0.64 mm(3) in two months old rats. Mean intravitreal ink volumes immediately after injection were 0.8 mm(3) for 1 ml injections, 2 mm( 3) for 3 ml, 2.3 to 2.6 mm(3) for 5 microl and 3.2 mm(3 ) for 10 microl. The percentage of vitreous volume involved by the injection ranged from 4.4% to 33.2%. The injected volume is limited by the large lens size of the rat. Extraocular loss of injected solution increases for higher injected volumes, with larger standard deviations. In this model, the dye tends to localize behind the lens. A 3 or 5 microl volume appears to have the best reproducibility with minimum loss of solution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402382     DOI: 10.1076/ceyr.22.1.74.6974

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  24 in total

1.  Intravitreal crystalline drug delivery for intraocular proliferation diseases.

Authors:  Lingyun Cheng; Karl Hostetler; Nadya Valiaeva; Ajay Tammewar; William R Freeman; James Beadle; Dirk-Uwe Bartsch; Kathy Aldern; Iryna Falkenstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-20       Impact factor: 4.799

2.  Feedback via Ca²⁺-activated ion channels modulates endothelin 1 signaling in retinal arteriolar smooth muscle.

Authors:  Michael Stewart; Maurice Needham; Peter Bankhead; Tom A Gardiner; C Norman Scholfield; Tim M Curtis; J Graham McGeown
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

3.  Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat.

Authors:  Mariana S Dias; Victor G Araujo; Taliane Vasconcelos; Qiuhong Li; William W Hauswirth; Rafael Linden; Hilda Petrs-Silva
Journal:  Gene Ther       Date:  2019-09-27       Impact factor: 5.250

4.  Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.

Authors:  Carolyn K Pan; Chandrasekar Durairaj; Uday B Kompella; Ogechi Agwu; Scott C N Oliver; Hugo Quiroz-Mercado; Naresh Mandava; Jeffrey L Olson
Journal:  J Ocul Pharmacol Ther       Date:  2011-05-16       Impact factor: 2.671

5.  The role of K+ and Cl- channels in the regulation of retinal arteriolar tone and blood flow.

Authors:  Maurice Needham; Mary K McGahon; Peter Bankhead; Tom A Gardiner; C Norman Scholfield; Tim M Curtis; J Graham McGeown
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-07       Impact factor: 4.799

6.  Exploration of the glutamate-mediated retinal excitotoxic damage: a rat model of retinal neurodegeneration.

Authors:  Ling Gao; Qi-Jun Zheng; Li-Qian-Yu Ai; Kai-Jian Chen; Yuan-Guo Zhou; Jian Ye; Wei Liu
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

7.  Contribution of voltage-gated sodium channels to the b-wave of the mammalian flash electroretinogram.

Authors:  Deb Kumar Mojumder; David M Sherry; Laura J Frishman
Journal:  J Physiol       Date:  2008-04-03       Impact factor: 5.182

8.  [Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression].

Authors:  T Jehle; W Meschede; R Dersch; N Feltgen; M Bach; W A Lagrèze
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

9.  Non-viral siRNA delivery into the mouse retina in vivo.

Authors:  Andrey Turchinovich; Georg Zoidl; Rolf Dermietzel
Journal:  BMC Ophthalmol       Date:  2010-10-01       Impact factor: 2.209

10.  Safety of intravitreally administered recombinant erythropoietin (an AOS thesis).

Authors:  James C Tsai
Journal:  Trans Am Ophthalmol Soc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.